https://www.selleckchem.com/products/mbx-8025.html
tegies for all women undergoing egg freezing. Temelimab (formerly called GNbAC1) is an immunoglobulin (Ig)G4 monoclonal antibody that targets the human endogenous retroviral envelope protein HERV-W-Env, shown to be associated with the pathogenesis of certain autoimmune disorders such as multiple sclerosis (MS) and type 1 diabetes mellitus (T1D). By neutralizing HERV-W-Env, temelimab could act as a disease-modifying therapy for these disorders. It is currently in clinical development for MS and T1D. The safety information on temelimab (
Like
Comment
Share
